Skip to main content
Livermore
Livermore
ZHEN

Neuberger Berman Group LLC

SEC CIK
0001465109
Latest filing
Aug 13, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Neuberger Berman Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
421,976
Value
$263.1M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of REGN by Neuberger Berman Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026421,976$263.1M0.2%−5,153−1.2%ReducedHolders
Q1 2026427,129$330.1M0.3%+5,002+1.2%AddedHolders
Q4 2025422,127$325.8M0.2%+6,413+1.5%AddedHolders
Q3 2025415,714$233.7M0.2%+10,520+2.6%AddedHolders
Q2 2025405,194$212.7M0.2%−31,314−7.2%ReducedHolders
Q1 2025436,508$276.8M0.2%−26,021−5.6%ReducedHolders
Q4 2024462,529$329.5M0.3%+12,939+2.9%AddedHolders
Q3 2024449,590$472.6M0.4%−6,210−1.4%ReducedHolders
Q2 2024455,800$479.1M0.4%+4,116+0.9%AddedHolders
Q1 2024451,684$434.7M0.4%−14,205−3.0%ReducedHolders
Q4 2023465,889$409.2M0.4%−241,922−34.2%ReducedHolders
Q3 2023707,811$582.6M0.5%−852−0.1%ReducedHolders
Q2 2023708,663$509.1M0.5%+19,784+2.9%AddedHolders
Q1 2023688,879$566.0M0.5%+39,229+6.0%AddedHolders
Q4 2022649,650$468.7M0.5%+58,411+9.9%AddedHolders
Q3 2022591,239$407.3M0.4%−50,160−7.8%ReducedHolders
Q2 2022641,399$379.2M0.4%+44,875+7.5%AddedHolders
Q1 2022596,524$416.6M0.4%−3,308−0.6%ReducedHolders
Q4 2021599,832$378.0M0.3%+40,234+7.2%AddedHolders
Q3 2021559,598$338.3M0.3%−174,484−23.8%ReducedHolders
Q2 2021734,082$409.6M0.4%−21,707−2.9%ReducedHolders
Q1 2021755,789$357.4M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.